JP2020502197A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020502197A5 JP2020502197A5 JP2019533180A JP2019533180A JP2020502197A5 JP 2020502197 A5 JP2020502197 A5 JP 2020502197A5 JP 2019533180 A JP2019533180 A JP 2019533180A JP 2019533180 A JP2019533180 A JP 2019533180A JP 2020502197 A5 JP2020502197 A5 JP 2020502197A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition
- composition according
- perfluorobutyl
- pentane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 20
- 239000000203 mixture Substances 0.000 claims 16
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 claims 10
- 108010036949 Cyclosporine Proteins 0.000 claims 10
- 229960001265 ciclosporin Drugs 0.000 claims 10
- 229930182912 cyclosporin Natural products 0.000 claims 10
- 208000003556 Dry Eye Syndromes Diseases 0.000 claims 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 8
- 229930105110 Cyclosporin A Natural products 0.000 claims 3
- -1 polyethylene Polymers 0.000 claims 2
- 239000004698 Polyethylene Substances 0.000 claims 1
- 239000004743 Polypropylene Substances 0.000 claims 1
- 239000000607 artificial tear Substances 0.000 claims 1
- 210000000795 conjunctiva Anatomy 0.000 claims 1
- 210000004087 cornea Anatomy 0.000 claims 1
- 206010013932 dyslexia Diseases 0.000 claims 1
- 230000007794 irritation Effects 0.000 claims 1
- 229920000573 polyethylene Polymers 0.000 claims 1
- 229920001155 polypropylene Polymers 0.000 claims 1
- 238000010186 staining Methods 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 239000012815 thermoplastic material Substances 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021215498A JP2022050514A (ja) | 2016-12-23 | 2021-12-31 | ドライアイ疾患の治療のための眼科用組成物 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16206735 | 2016-12-23 | ||
| EP16206735.9 | 2016-12-23 | ||
| EP17165578.0 | 2017-04-07 | ||
| EP17165578 | 2017-04-07 | ||
| PCT/EP2017/083770 WO2018115097A1 (en) | 2016-12-23 | 2017-12-20 | Ophthalmic composition for treatment of dry eye disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021215498A Division JP2022050514A (ja) | 2016-12-23 | 2021-12-31 | ドライアイ疾患の治療のための眼科用組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020502197A JP2020502197A (ja) | 2020-01-23 |
| JP2020502197A5 true JP2020502197A5 (enExample) | 2021-02-04 |
| JP7032404B2 JP7032404B2 (ja) | 2022-03-08 |
Family
ID=61002978
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019533180A Active JP7032404B2 (ja) | 2016-12-23 | 2017-12-20 | ドライアイ疾患の治療のための眼科用組成物 |
| JP2021215498A Withdrawn JP2022050514A (ja) | 2016-12-23 | 2021-12-31 | ドライアイ疾患の治療のための眼科用組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021215498A Withdrawn JP2022050514A (ja) | 2016-12-23 | 2021-12-31 | ドライアイ疾患の治療のための眼科用組成物 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20180360908A1 (enExample) |
| EP (3) | EP3777830B1 (enExample) |
| JP (2) | JP7032404B2 (enExample) |
| KR (1) | KR102288022B1 (enExample) |
| CN (1) | CN110267645A (enExample) |
| AU (1) | AU2017384650B2 (enExample) |
| BR (1) | BR112019012791A2 (enExample) |
| CA (1) | CA3045743C (enExample) |
| DK (1) | DK3399962T3 (enExample) |
| ES (2) | ES2965883T3 (enExample) |
| MX (1) | MX381639B (enExample) |
| PL (1) | PL3399962T3 (enExample) |
| PT (1) | PT3399962T (enExample) |
| WO (1) | WO2018115097A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112012023421B1 (pt) | 2010-03-17 | 2021-09-14 | Novaliq Gmbh | Composição farmacêutica para tratamento de aumento de pressão intraocular |
| EP2444063A1 (en) | 2010-10-20 | 2012-04-25 | Novaliq GmbH | Liquid pharmaceutical compositions for the delivery of active ingredients |
| CA3142049C (en) | 2012-09-12 | 2023-08-29 | Novaliq Gmbh | Semifluorinated alkane compositions |
| CA2997744C (en) | 2012-09-12 | 2019-12-31 | Novaliq Gmbh | Compositions comprising mixtures of semifluorinated alkanes |
| CA2918419C (en) | 2013-07-23 | 2022-05-03 | Novaliq Gmbh | Stabilized antibody compositions |
| WO2017055454A1 (en) | 2015-09-30 | 2017-04-06 | Novaliq Gmbh | Semifluorinated compounds and their compositions |
| DK3356313T3 (da) | 2015-09-30 | 2020-07-20 | Novaliq Gmbh | 2-perfluorhexyloktan til oftalmisk indgivelse |
| JP2019520357A (ja) | 2016-06-23 | 2019-07-18 | ノバリック ゲーエムベーハー | 局所投与方法 |
| WO2018054932A1 (en) | 2016-09-22 | 2018-03-29 | Novaliq Gmbh | Pharmaceutical compositions for use in the therapy of blepharitis |
| CN109906085B (zh) | 2016-09-23 | 2024-03-08 | 诺瓦利克有限责任公司 | 含有环孢素的眼用组合物 |
| PL3612228T3 (pl) | 2017-04-21 | 2024-04-08 | Dermaliq Therapeutics, Inc. | Kompozycje jodu |
| US11278503B2 (en) | 2017-05-12 | 2022-03-22 | Novaliq Gmbh | Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditions |
| SG11202002640YA (en) | 2017-09-27 | 2020-04-29 | Novaliq Gmbh | Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases |
| US11896559B2 (en) | 2017-10-04 | 2024-02-13 | Novaliq Gmbh | Opthalmic compositions comprising F6H8 |
| CA3091308A1 (en) | 2018-03-02 | 2019-09-06 | Novaliq Gmbh | Pharmaceutical compositions comprising nebivolol |
| WO2019206956A1 (en) | 2018-04-27 | 2019-10-31 | Novaliq Gmbh | Ophthalmic compositions comprising tafluprost for the treatment of glaucoma |
| US12472162B2 (en) * | 2018-07-24 | 2025-11-18 | Carefusion 213, Llc | Ready-to-use, terminally sterile packaging for surgical antiseptic and method of use |
| MY206642A (en) * | 2018-10-12 | 2024-12-30 | Novaliq Gmbh | Ophthalmic composition for treatment of dry eye disease |
| US12397039B2 (en) | 2019-02-13 | 2025-08-26 | Novaliq Gmbh | Compositions and methods for the treatment of ocular neovascularization |
| US20220226426A1 (en) * | 2019-05-24 | 2022-07-21 | Novaliq Gmbh | Ophthalmic composition for the treatment of ocular allergy |
| AU2020340561A1 (en) * | 2019-09-06 | 2022-03-31 | Novaliq Gmbh | Ophthalmic composition for the treatment of uveitis |
| EP3861857A1 (en) * | 2020-02-07 | 2021-08-11 | Novaliq GmbH | Antiparasitic compositions |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2335735A1 (en) * | 2009-12-14 | 2011-06-22 | Novaliq GmbH | Pharmaceutical composition for treatment of dry eye syndrome |
| WO2013126602A1 (en) * | 2012-02-21 | 2013-08-29 | Massachusetts Eye & Ear Infirmary | Inflammatory eye disorders |
| US9878000B2 (en) * | 2012-06-20 | 2018-01-30 | University Of Waterloo | Mucoadhesive nanoparticle composition comprising immunosuppresant and methods of use thereof |
| CA2997744C (en) * | 2012-09-12 | 2019-12-31 | Novaliq Gmbh | Compositions comprising mixtures of semifluorinated alkanes |
| KR20150095684A (ko) * | 2012-12-18 | 2015-08-21 | 노파르티스 아게 | 히알루로난에 결합하는 펩티드 태그를 이용하는 조성물 및 방법 |
| CN106572941B (zh) * | 2014-08-13 | 2020-06-23 | 佛罗里达大学研究基金会股份有限公司 | 从眼药水中去除防腐剂 |
-
2017
- 2017-12-20 ES ES20178792T patent/ES2965883T3/es active Active
- 2017-12-20 WO PCT/EP2017/083770 patent/WO2018115097A1/en not_active Ceased
- 2017-12-20 PL PL17832066T patent/PL3399962T3/pl unknown
- 2017-12-20 ES ES17832066T patent/ES2819005T3/es active Active
- 2017-12-20 BR BR112019012791A patent/BR112019012791A2/pt not_active Application Discontinuation
- 2017-12-20 EP EP20178792.6A patent/EP3777830B1/en active Active
- 2017-12-20 DK DK17832066.9T patent/DK3399962T3/da active
- 2017-12-20 CN CN201780079941.0A patent/CN110267645A/zh active Pending
- 2017-12-20 KR KR1020197021384A patent/KR102288022B1/ko active Active
- 2017-12-20 CA CA3045743A patent/CA3045743C/en active Active
- 2017-12-20 MX MX2019007587A patent/MX381639B/es unknown
- 2017-12-20 JP JP2019533180A patent/JP7032404B2/ja active Active
- 2017-12-20 EP EP23212280.4A patent/EP4374851A3/en active Pending
- 2017-12-20 AU AU2017384650A patent/AU2017384650B2/en active Active
- 2017-12-20 EP EP17832066.9A patent/EP3399962B1/en active Active
- 2017-12-20 PT PT178320669T patent/PT3399962T/pt unknown
-
2018
- 2018-08-22 US US16/109,127 patent/US20180360908A1/en not_active Abandoned
-
2021
- 2021-12-31 JP JP2021215498A patent/JP2022050514A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020502197A5 (enExample) | ||
| ES2819005T3 (es) | Composición oftálmica para el tratamiento de la enfermedad del ojo seco | |
| Heuschkel et al. | Microemulsions—modern colloidal carrier for dermal and transdermal drug delivery | |
| KR102614858B1 (ko) | 안검염 치료에 사용되는 약제학적 조성물 | |
| Tangri et al. | Basics of ocular drug delivery systems | |
| US8758816B2 (en) | Compositions comprising azelastine and methods of use thereof | |
| PE20041024A1 (es) | Sistema de liberacion controlada | |
| JP2018506570A5 (enExample) | ||
| JP2009501797A5 (enExample) | ||
| CN107530317A (zh) | 大麻素类和n‑酰基乙醇胺的组合 | |
| US6204270B1 (en) | Ophthalmic and mucosal preparations | |
| IL276888B2 (en) | Pharmaceutical composition comprising timolol | |
| WO2013065720A1 (ja) | 眼科用水性組成物 | |
| IL293188B1 (en) | Varenicline compound for use as a medication for treating dry eye, increasing tear production and treating eye discomfort and a pramipexole preparation containing varenicline | |
| IL275339B1 (en) | Parasitic formulations containing isoxazoline and methods for treating blepharitis | |
| JP5873573B2 (ja) | 水性眼科組成物 | |
| WO2016208961A1 (ko) | 이마티닙을 유효성분으로 포함하는 안구 건조 질환 예방 및 치료용 약학 조성물 | |
| US10357528B2 (en) | Composition for treating corneal diseases or conjunctival diseases | |
| JPWO2006087968A1 (ja) | 眼科用固形外用薬剤 | |
| KR101433396B1 (ko) | 안구 적용용 아마인 추출물 약제 | |
| JP2011093889A (ja) | 洗眼剤 | |
| EP3199163A1 (en) | Composition of doxycycline in liposomes for the prevention, improvement and/or treatment of ocular pathologies | |
| JPH0977656A (ja) | 点眼用エアゾル組成物 | |
| Ebigwai et al. | Activity of crude cold-water extract of the culinary-medicinal oyster mushroom, Pleurotus ostreatus (Jacq.: Fr.) P. Kumm.(higher Basidiomycetes), and timolol maleate on induced ocular hypertension | |
| CN115427034A (zh) | 非甾体抗炎药合成物及其使用方法 |